Drug Profile
SPM 4757
Latest Information Update: 08 Aug 1994
Price :
$50
*
At a glance
- Originator Schwarz Pharma
- Class Ischaemic heart disorder therapies; Organic nitrates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris